drugset / Trial / NCT03271697

Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage

NCT03271697

Phase 2/3 Unknown 120 enrolled China Medical University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

This research is trying to see if AM can enhance the clinical prognosis for spontaneous aneurysm ruptured subarachnoid hemorrhage patients.

Timeline

Start
2017-09
Primary completion
2020-09
Completion
2020-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Astragalus Traditional medicine (herbal / TCM)